growing at a CAGR of 7.5% from 2015 to 2020. The market is categorized on the basis of route of administration, end user, and region. The route of administration market is further segmented into oral, pulmonary, ocular, nasal, topical, injectable, implantable and transmucosal drug delivery technology. The topical drug delivery technology market segment is expected to witness the highest CAGR in the forecast period. Factors such as rising incidences of chronic diseases, growth of the biologics market, and innovation and technological advancements, are driving the growth of the drug delivery technology market. In addition, emphasis on innovation for improving the delivery of drugs is also contributing to the growth of the market. For instance, in February 2015, Sanofi and Mankind Corporation (U.S.) collaborated to launch Afrezza (insulin human) Inhalation Powder, inhalable insulin. This launch enabled the company to strengthen its product portfolio in nasal drug delivery. Such innovations are fueling the growth of the market. Asia is expected to be the fastest-growing region in the market. High growth in this market can be attributed to the increased population, rising prevalence of chronic diseases in the emerging markets, and existence of unmet medical needs. Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Browse Complete Report with TOC @http://www.idatainsights.com/reports-landing-page.php?id=150932/drug-delivery-technology-market-by-route-of-administration-oral-solid-pulmonary-nebulizer-injectable-device-ocular-liquid-nasal-drop-topical-solid-implantable-active-transmucosal-oral-end-user-hospital-asc-home-care-forecast-to-2020
To Get Sample Copy of Report visit @http://www.idatainsights.com/reports-landing-page.php?id=150932/drug-delivery-technology-market-by-route-of-administration-oral-solid-pulmonary-nebulizer-injectable-device-ocular-liquid-nasal-drop-topical-solid-implantable-active-transmucosal-oral-end-user-hospital-asc-home-care-forecast-to-2020
Table of Contents
6.7.3 Solid Topical Drug Delivery
6.7.4 Transdermal Drug Delivery
220.127.116.11 Transdermal Patches
18.104.22.168 Transdermal Gels
6.8 Implantable Drug Delivery
6.8.1 Active Implantable Drug Delivery
6.8.2 Passive Implantable Drug Delivery
6.9 Transmucosal Drug Delivery
6.9.1 Oral Transmucosal Drug Delivery
22.214.171.124 Buccal Drug Delivery
126.96.36.199 Sublingual Drug Delivery
6.9.2 Other Transmucosal Drug Delivery
188.8.131.52 Rectal Transmucosal Drug Delivery
184.108.40.206 Vaginal Transmucosal Drug Delivery
7 Drug Delivery Technology Market, By End User (Page No. - 137)
7.3 Home Care Settings
7.4 Ambulatory Surgical Centers/Clinics
7.5 Diagnostic Centers
7.6 Other End Users
8 Drug Delivery Technology Market, By Region (Page No. - 145)
8.2 North America
8.5 Rest of the World
9 Competitive Landscape (Page No. - 163)
9.2 Market Share Analysis
9.3 Competitive Situations & Trends
9.3.1 New Product Launches & Approvals
9.3.2 Partnerships, Agreements, and Collaborations
10 Company Profiles (Page No. - 171)
(Overview, Financials, Products & Services, Strategy, & Developments)*
10.2 Bayer AG
10.3 Johnson & Johnson Services, Inc.
10.4 Novartis AG
10.5 Pfizer, Inc.
10.6 F. Hoffmann-La Roche Ltd.
10.7 3M Company
10.8 Antares Pharma, Inc.
10.9 Glaxosmithkline PLC
10.10 Merck & Co., Inc.
*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.
11 Appendix (Page No. - 222)
11.1 Insights From Industry Experts
11.2 Discussion Guide
11.3 Other Developments, 20122015
11.4 Available Customizations
11.5 RT: Real-Time Market Intelligence
11.6 Related Reports
Read More http://www.idatainsights.com/reports-landing-page.php?id=150932/drug-delivery-technology-market-by-route-of-administration-oral-solid-pulmonary-nebulizer-injectable-device-ocular-liquid-nasal-drop-topical-solid-implantable-active-transmucosal-oral-end-user-hospital-asc-home-care-forecast-to-2020
iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firAssadsa We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.
We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects